Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Perrigo Company plc
  6. Summary
    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/08/2021 06/09/2021 06/10/2021 06/11/2021 06/14/2021 Date
47.03(c) 47.07(c) 48.87(c) 47.73(c) 47.73 Last
798 014 1 312 688 1 220 957 1 153 215 1 249 410 Volume
+0.62% +0.09% +3.82% -2.33% 0.00% Change
More quotes
Financials (USD)
Sales 2021 4 218 M - -
Net income 2021 194 M - -
Net Debt 2021 1 057 M - -
P/E ratio 2021 -367x
Yield 2021 2,11%
Sales 2022 4 350 M - -
Net income 2022 235 M - -
Net Debt 2022 751 M - -
P/E ratio 2022 104x
Yield 2022 2,32%
Capitalization 6 374 M 6 374 M -
EV / Sales 2021 1,76x
EV / Sales 2022 1,64x
Nbr of Employees 11 500
Free-Float 98,8%
More Financials
Company
Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises... 
Read more
Sector
Pharmaceuticals
Calendar
06/16 | 09:05amPresentation
More about the company
Ratings of Perrigo Company plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PERRIGO COMPANY PLC
06/03PERRIGO COMPANY PLC : Ex-dividend day for
FA
05/21PERRIGO  : To Present Virtually At Upcoming Consumer Investor Conferences
PR
05/18PERRIGO  : to Sell Mexico, Brazil OTC Businesses to Advent International
MT
05/17Luxury yacht maker Italian Sea Group secures Armani's backing in IPO
RE
05/14PERRIGO CO PLC  : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/13PERRIGO  : Says Irish Revenue Rejects Offer to Settle Disputed 1.64 Billion Euro..
MT
05/12PERRIGO  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/12PERRIGO  : REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIO..
PU
05/11INSIDER TRENDS : Insider at Perrigo Company Exercises Options in Mist of 90-Day ..
MT
05/11INSIDER TRENDS : Perrigo Company Insider Exercises Option/Derivative Security to..
MT
05/11INSIDER TRENDS : Insider at Perrigo Company Acquires Stock Via Conversion of Opt..
MT
05/11INSIDER TRENDS : Perrigo Company Insider Converts Option/Derivative Security Sel..
MT
05/11INSIDER TRENDS : Insider at Perrigo Company Acquires Stock Via Option/Derivative..
MT
05/11PERRIGO  : First Quarter 2021 Financial Results
PU
05/11PERRIGO  : Fiscal Q1 Earnings, Revenue Drop
MT
More news
News in other languages on PERRIGO COMPANY PLC
05/10L'agenda di domani
05/10L'agenda della settimana
05/07L'agenda della prossima settimana
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -4-
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -2-
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Analysis
S&P 500 surges in strongest one-day rise since June
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 50,83 $
Last Close Price 47,73 $
Spread / Highest target 34,1%
Spread / Average Target 6,50%
Spread / Lowest Target -5,72%
EPS Revisions
Managers and Directors
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Raymond P. Silcock CFO, Principal Accounting Officer & Executive VP
Rolf Allan Classon Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC6.73%6 374
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857